Abstract
We performed serial histories, physical examinations, and nerve conduction studies on seven cancer patients who were treated with cis-diamminedichloroplatinum(II). Total cumulative doses ranged from 200 to 350 mg/m2. In nerve conduction studies, three of seven patients showed subclinical, predominantly sensory, changes compatible with a peripheral neuropathy.
Original language | English (US) |
---|---|
Pages (from-to) | 1119-1122 |
Number of pages | 4 |
Journal | Cancer Treatment Reports |
Volume | 64 |
Issue number | 10-11 |
State | Published - 1980 |
ASJC Scopus subject areas
- Oncology
- Cancer Research